PharmacologyNMC Grounded

First-Line Anti-Tubercular Drugs (HRZE): MOA, Toxicities & KD Tripathi Pearls

KD Tripathi Essentials of Medical Pharmacology (8th Ed, Chapter 56 - Antimycobacterial Drugs)

High-Yield Clinical Pearls & Exam Keys

1

Isoniazid (INH) is a prodrug activated by mycobacterial catalase-peroxidase enzyme (KatG), which then inhibits mycolic acid synthesis by targeting InhA.

2

Rifampicin binds to the beta subunit of bacterial DNA-dependent RNA polymerase, blocking transcription. Causes benign orange-red discoloration of body fluids.

3

Pyrazinamide is active in acidic intracellular environments (caseous necrosis), converted to pyrazinoic acid by pyrazinamidase. Most hepatotoxic first-line ATT.

4

Ethambutol is the ONLY bacteriostatic first-line ATT drug. Inhibits arabinosyl transferase (embB), causing dose-dependent Retrobulbar Optic Neuritis (loss of red-green vision).

Ask Dr. Medarro about Pharmacology

Instant NMC-grounded answers with standard textbook citations

Or tap a high-yield exam question:

First-Line ATT (HRZE) Quick Summary Matrix

Drug NameMechanism of Action (MOA)Key Toxicity / Clinical Pearl
Isoniazid (H)Inhibits mycolic acid synthesis via KatG activationPeripheral neuropathy (prevented with Pyridoxine Vit B6), Hepatotoxicity, Drug-induced SLE
Rifampicin (R)Inhibits DNA-dependent RNA Polymerase (beta subunit)Potent CYP3A4 enzyme inducer, Orange-red urine/sweat, Hepatotoxicity
Pyrazinamide (Z)Disrupts mycobacterial membrane potential in acidic pHHyperuricemia (Gout), Highest hepatotoxicity among all first-line drugs
Ethambutol (E)Inhibits arabinosyl transferase (blocks arabinogalactan)Retrobulbar optic neuritis (Decreased visual acuity, red-green color blindness), Safe in renal/hepatic failure with dose adjustments

Interactive Clinical Vignette Practice

Live Rule-Out Engine
Case Vignette #1NEET-PG Calibrated

A 45-year-old male with pulmonary tuberculosis on HRZE therapy complains of difficulty reading newspapers and distinguishes traffic light colors poorly. Visual acuity testing reveals decreased bilateral central vision. Which drug is responsible?

AIsoniazid
BRifampicin
CEthambutol
DPyrazinamide
Free Student Account Required

Unlock Complete Viva Traps & Additional Case Vignettes

Access model examiner answers, comprehensive rule-out breakdowns, and 4K spotter explanations.

Free student account•No credit card required
Medarro Study Hub

Want 50+ Clinical Vignettes & 4K 3D Spotters on Pharmacology?

Practice Spaced Repetition Decathlon, generate instant 7-day adaptive study plans, and upload your college PDFs into the personal vault.

Related High-Yield Chapters